Evidence map›Paper›PMID 37280721›Full record

ArticleNMR in biomedicine2023

A machine learning approach that measures pH using acidoCEST MRI of iopamidol.

Tianzhe Li, Julio Cárdenas-Rodríguez, Priya N Trakru, Mark D Pagel

Open access · greenAbstract read
In one paragraph

Article in NMR in biomedicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Tianzhe LiThe University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Julio Cárdenas-RodríguezData Translators LLC, Oro Valley, Arizona, USA.
Priya N TrakruThe University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Mark D PagelThe University of Texas MD Anderson Cancer Center, Houston, Texas, USA.ORCID 0000-0002-8109-3995
The University of Texas MD Anderson Cancer Center · USNimbis Services (United States) · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI DIANE BODURKA · 1985 to 2026
$290.8M
Development and Dissemination of Clinical CEST MRI Acquisition and Analysis Methods for Cancer Imaging ApplicationsR01CA231513 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI MA, JINGFEI, PAGEL, MARK DAVID · 2019 to 2023
$3.1M
NCI NIH HHS P30 CA016672NCI NIH HHS R01 CA231513
6 · The paper itself

Abstract

Tumor acidosis is an important biomarker for aggressive tumors, and extracellular pH (pHe) of the tumor microenvironment can be used to predict and evaluate tumor responses to chemotherapy and immunotherapy. AcidoCEST MRI measures tumor pHe by exploiting the pH-dependent chemical exchange saturation transfer (CEST) effect of iopamidol, an exogenous CT agent repurposed for CEST MRI. However, all pH fitting methodologies for acidoCEST MRI data have limitations. Herein we present results of the application of machine learning for extracting pH values from CEST Z-spectra of iopamidol. We acquired 36,000 experimental CEST spectra from 200 phantoms of iopamidol prepared at five concentrations, five T

Indexed as

IopamidolNeoplasmsHumansHydrogen-Ion ConcentrationMachine LearningMagnetic Resonance ImagingTumor MicroenvironmentIopamidolCEST MRIiopamidolmachine learningmolecular imagingquantitative MRItumor pH

Identifiers

PMID37280721
PMCPMC10529789
OpenAlexW4379599276

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.